Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
Comparative Study
. 2001 Apr;31(2):183-94.
doi: 10.1023/a:1010751232295.

Assessment of Neural Cell Adhesion Molecule (NCAM) in Autistic Serum and Postmortem Brain

Comparative Study

Assessment of Neural Cell Adhesion Molecule (NCAM) in Autistic Serum and Postmortem Brain

A E Purcell et al. J Autism Dev Disord. .


Studies have identified structural abnormalities in areas of the autistic brain, with a pattern suggesting that a neurodevelopmental anomaly took place. Neural cell adhesion molecule (NCAM), which is involved in development of the central nervous system, was previously shown to be decreased in the serum of autistic individuals. In the present study, we measured NCAM protein in the sera from controls, patients with autism, siblings of autistic patients, and individuals with other neurologic disorders, but found no significant differences. We also measured NCAM protein in autistic postmortem brain samples and found the longest isoform, NCAM-180, to be significantly decreased. In addition, we investigated the mRNA expression of NCAM in these brain samples using cDNA microarrays and RT-PCR. Results show that NCAM mRNA levels are not altered in autism.

Similar articles

See all similar articles

Cited by 4 articles


    1. Science. 1987 May 15;236(4803):799-806 - PubMed
    1. Biochem J. 1993 Nov 1;295 ( Pt 3):833-40 - PubMed
    1. Neurochem Res. 1995 May;20(5):533-47 - PubMed
    1. Exp Gerontol. 1998 Nov-Dec;33(7-8):853-64 - PubMed
    1. J Neurochem. 1989 Nov;53(5):1372-8 - PubMed

Publication types

LinkOut - more resources